Connect to other sites within the UBM Medica Network
Video: Roberto Soto, MD, discusses his experience with PET imaging with Amyvid for Alzheimer’s evaluation, including reimbursement, training, and benefits of the new test.
PET/CT Bests Biopsy in Lymphoma Progression to Bone Marrow
18F-FDG PET/CT can better assess bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma than can standard bone biopsy.
PET/MR Requires New Technologist Standards
Nuclear medicine and MR technologists recommend regulations around education, certification and staffing for the new hybrid technology.
PET May Indicate Which Patients Benefit from Antidepressants
PET images may help determine which patients with major depression will respond best to medication or to cognitive behavior therapy.
PET Shows Nicotine in Smokers’ Brains Despite Vaccine
PET imaging aids researchers in search for anti-nicotine vaccine, but shows there is still a lot of work to do.
CMS to Cover Three Oncology FDG-PET Scans
CMS has agreed to cover three oncology FDG-PET scans, a revision from the proposed single-scan coverage, and one PET advocates lauded.
SPECT/MR Debuts as New Hybrid Modality
SPECT/MR debuted this week at the SNMMI annual meeting as a new preclinical hybrid molecular imaging system with promises of higher resolution and lower dose.
PET Shows Highly Educated Alzheimer’s Patients Cope Better
PET images show why education can help people cope with the effects of Alzheimer’s disease in its early stages.
PET Imaging with Amyvid for Alzheimer's
Video: Roberto Soto, MD, discusses using PET imaging with Amyvid for Alzheimer’s evaluation, including reimbursement, training, and benefits of the new test.
Case Study: PET Imaging with Amyvid for Alzheimer’s
Video: Roberto Soto, MD, of Precision Imaging, shows a recent PET imaging case using Amyvid, recently approved for evaluation of Alzheimer's.
Podcast: Advantages of Hybrid PET/MR
Osman Ratib, MD, PhD, FAHA, professor and chief of nuclear medicine in the Department of Radiology at the University Hospital of Geneva, discusses the advantages and future of the hybrid PET/MR modality.